Naturally occurring p16 Ink4a-positive cells shorten healthy lifespan

Nature

Volumn 530, Issue 7589, 2016, Pages 184-189

  Baker, Darren J ^a   Childs, Bennett G ^a   Durik, Matej ^a   Wijers, Melinde E ^a   Sieben, Cynthia J ^a   Zhong, Jian ^a   A Saltness, Rachel ^a   Jeganathan, Karthik B ^a   Verzosa, Grace Casaclang ^a   Pezeshki, Abdulmohammad ^a   Khazaie, Khashayarsha ^a   Miller, Jordan D ^a   Van Deursen, Jan M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; POTASSIUM CHANNEL;

AGE STRUCTURE; ANATOMY; BIOENGINEERING; CELLS AND CELL COMPONENTS; GENE EXPRESSION; GROWTH RESPONSE; LIFE CYCLE; PHYSIOLOGICAL RESPONSE; RODENT; SENESCENCE;

ADIPOCYTE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL AGING; GLOMERULOSCLEROSIS; HEART; KIDNEY; KIDNEY EPITHELIUM; LIFESPAN; MOUSE; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; AGING; ANIMAL; ANTIBODY SPECIFICITY; CARDIAC MUSCLE; CELL SEPARATION; CELL TRANSFORMATION; CYTOLOGY; EPITHELIUM CELL; FEMALE; HEALTH; LIPODYSTROPHY; LONGEVITY; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL; TIME FACTOR;

MUS;

ADIPOCYTES; AGING; ANIMALS; APOPTOSIS; CELL AGING; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EPITHELIAL CELLS; FEMALE; HEALTH; KIDNEY; LIPODYSTROPHY; LONGEVITY; MALE; MICE; MYOCARDIUM; ORGAN SPECIFICITY; STEM CELLS; TIME FACTORS;

EID: 84958093401     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature16932     Document Type: Article

References (50)

1. Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705 (2013).
2. Sharpless, N. E., Sherr, C. J. Forging a signature of in vivo senescence. Nature Rev. Cancer 15, 397-408 (2015).
3. van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439-446 (2014).
4. Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232-236 (2011).
5. Baker, D. J. et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nature Cell Biol. 10, 825-836 (2008).
6. Jun, J. I., Lau, L. F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nature Cell Biol. 12, 676-685 (2010).
7. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667 (2008).
8. Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722-733 (2014).
9. Munõz-Espin, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104-1118 (2013).
10. Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119-1130 (2013).
11. Wang, W., Wu, J., Zhang, Z., Tong, T. Characterization of regulatory elements on the promoter region of p16INK4a that contribute to overexpression of p16 in senescent fibroblasts. J. Biol. Chem. 276, 48655-48661 (2001).
12. Tchkonia, T. et al. Fat tissue, aging, and cellular senescence. Aging Cell 9, 667-684 (2010).
13. Liu, Y. et al. Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell 8, 439-448 (2009).
14. Wang, C., Li, Q., Redden, D. T., Weindruch, R., Allison, D. B. Statistical methods for testing effects on "maximum lifespan". Mech. Ageing Dev. 125, 629-632 (2004).
15. Goodrick, C. L., Ingram, D. K., Reynolds, M. A., Freeman, J. R., Cider, N. Effects of intermittent feeding upon body weight and lifespan in inbred mice: interaction of genotype and age. Mech. Ageing Dev. 55, 69-87 (1990).
16. Blackwell, B. N., Bucci, T. J., Hart, R. W., Turturro, A. Longevity, body weight, and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open formula diet. Toxicol. Pathol. 23, 570-582 (1995).
17. Bronson, R. T., Lipman, R. D. Reduction in rate of occurrence of age related lesions in dietary restricted laboratory mice. Growth Dev. Aging 55, 169-184 (1991).
18. Conti, B. et al. Transgenic mice with a reduced core body temperature have an increased life span. Science 314, 825-828 (2006).
19. Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799-3810 (2003).
20. Forster, M. J., Morris, P., Sohal, R. S. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J. 17, 690-692 (2003).
21. Ikeno, Y. et al. Housing density does not influence the longevity effect of calorie restriction. J. Gerontol. A Biol. Sci. Med. Sci. 60, 1510-1517 (2005).
22. Kunstyr, I., Leuenberger, H. G. Gerontological data of C57BL/6J mice. I. Sex differences in survival curves. J. Gerontol. 30, 157-162 (1975).
23. Selman, C. et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22, 807-818 (2008).
24. Sohal, R. S., Ku, H. H., Agarwal, S., Forster, M. J., Lal, H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74, 121-133 (1994).
25. Srivastava, V. K., Tilley, R. D., Hart, R. W., Busbee, D. L. Effect of dietary restriction on the fidelity of DNA polymerases in aging mice. Exp. Gerontol. 26, 453-466 (1991).
26. Turturro, A. et al. Growth curves and survival characteristics of the animals used in the biomarkers of aging program. J. Gerontol. A Biol. Sci. Med. Sci. 54, B492-B501 (1999).
27. Yuan, R. et al. Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains. Proc. Natl Acad. Sci. USA 109, 8224-8229 (2012).
28. Zhang, Y. et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife 1, e00065 (2012).
29. Richardson, A. et al. Measures of healthspan as indices of aging in mice-a recommendation. J. Gerontol. A Biol. Sci. Med. Sci. http:://dx.doi.org/10.1093/gerona/glv080 (2015).
30. Razzaque, M. S. Does renal ageing affect survival? Ageing Res. Rev. 6, 211-222 (2007).
31. Ferder, L. F., Inserra, F., Basso, N. Effects of renin-angiotensin system blockade in the aging kidney. Exp. Gerontol. 38, 237-244 (2003).
32. Paul, M., Poyan Mehr, A., Kreutz, R. Physiology of local renin-angiotensin systems. Physiol. Rev. 86, 747-803 (2006).
33. Bernhard, D., Laufer, G. The aging cardiomyocyte: a mini-review. Gerontology 54, 24-31 (2008).
34. Sudhir, R., Sukhodub, A., Du, Q., Jovanovic, S., Jovanovic, A. Ageing-induced decline in physical endurance in mice is associated with decrease in cardiac SUR2A and increase in cardiac susceptibility to metabolic stress: therapeutic prospects for up-regulation of SUR2A. Biogerontology 12, 147-155 (2011).
35. Baker, D. J. et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nature Cell Biol. 15, 96-102 (2012).
36. Childs, B. G., Durik, M., Baker, D. J., van Deursen, J. M. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nature Med. 21, 1424-1435 (2015).
37. Baker, D. J., Weaver, R. L., van Deursen, J. M. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep. 3, 1164-1174 (2013).
38. Baker, D. J. et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nature Cell Biol. 15, 96-102 (2013).
39. Zingman, L. V. et al. Kir6.2 is required for adaptation to stress. Proc. Natl Acad. Sci. USA 99, 13278-13283 (2002).
40. Wijshake, T. et al. Reduced life-and healthspan in mice carrying a mono-allelic BubR1 MVA mutation. PLoS Genet. 8, e1003138 (2012).
41. Buenz, E. J. et al. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am. J. Pathol. 175, 668-684 (2009).
42. Maskey, R. S. et al. Spartan deficiency causes genomic instability and progeroid phenotypes. Nature Commun. 5, 5744 (2014).
43. Blatner, N. R. et al. Expression of ROR?t marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4, 164-159 (2012).
44. Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genet. 36, 744-749 (2004).
45. Stollewerk, A., Klambt, C., Cantera, R. Electron microscopic analysis of Drosophila midline glia during embryogenesis and larval development using ?-galactosidase expression as endogenous cell marker. Microsc. Res. Tech. 35, 294-306 (1996).
46. Garelick, M. G. et al. Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo. Cell Cycle 12, 2493-2504 (2013).
47. Schreiber, K. H. et al. Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins. Aging Cell 14, 265-273 (2015).
48. Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genet. 36, 744-749 (2004).
49. Burd, C. E. et al. Monitoring tumorigenesis and senescence in vivo with a p16INK4a-luciferase model. Cell 152, 340-351 (2013).
50. Ricke, R. M., Jeganathan, K. B., Malureanu, L., Harrison, A. M., van Deursen, J. M. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression. J. Cell Biol. 199, 931-949 (2012).